Helicos Awarded 'Revolutionary Genome Sequencing Technologies - The $1000 Genome' Grant
Complete the form below to unlock access to ALL audio articles.
Helicos BioSciences has announced that it has received a $2 Million grant from the National Human Genome Research Institute (NHGRI) as part of the Institute’s "Revolutionary Genome Sequencing Technologies – The $1000 Genome" research program.
The grant will fund research of Helicos’ proprietary single molecule sequencing technology (tSMS™) for ultra low cost resequencing applications and de novo sequencing of large genomes.
The funds will accelerate Helicos’ efforts to revolutionize medicine by enabling the sequencing and characterization of genomes across thousands of samples.
"We are pleased that the NHGRI sees the value of the Helicos approach to deliver the promise of the $1000 genome," said Stan Lapidus, Helicos’ President and CEO.
"This grant allows us to accelerate our research efforts, which we believe will produce unprecedented sequencing performance on a platform that is easily scalable to large experiments including the sequencing of whole genomes."
"Experiments which involve extensive coverage of the genome and require hundreds or thousands of samples to achieve significant results are simply not possible today."
"These important experiments, such as elucidating the full range of DNA alterations in cancer, define a "No Man’s Land" in genomics."
"We believe our tSMS™ technology will enable investigators to navigate this nascent space."
The award will last three years and will focus on the development of novel methods of the tSMS™ assay.
